Leading the way with the industry’s largest portfolio of CE-IVD labeled flow cytometry reagents in the market, Beckman Coulter Life Sciences announces that it has received a EU Quality Management System Certificate under the new In Vitro Diagnostic Medical Devices Regulation (IVDR) for more than 200 flow cytometry reagents developed and manufactured at their Marseille, France facility.
New CEO for Galapagos
AppointmentsCo-founder and former board member of Galapagos NV Dr Paul Stoffels will take over the position of Chief Executive Officer at the Belgian company from April. He succeeds long-time CEO Onno van de Stolpe, who is retiring.
Detect the Omicron variant of SARS-CoV-2 with Meridian Bioscience’s new antibody pair
ProductsA rapid antigen test provides a fast and reliable indication of the presence of the SARS-CoV-2 virus, the causative agent of Covid-19. A positive result of an antigen test is reliable, whereas a negative result does not completely rule out infection with the SARS-CoV-2 virus. The success of rapid tests is therefore limited by the sensitivity of the antibodies used.
Viennese Ribbon Biolabs closes €18m Series A financing
Latest NewsRibbon Biolabs has cashed in €18m in Series A financing led by Hadean Ventures
mRNA specalist Ethris raises $26m in Series B financing
Latest NewsGerman mRNA and LNP specialist Ethris GmbH has closed a $26m Series B round led by Laureus Capital.
Evotec and Boehringer Ingelheim enter drug discovery deal
Latest NewsEvotec SE will use its PanOmics platform to validate and screen targets and drug candidates in ophtalmology for Boehringer Ingelheim.
BioNTech and Pfizer evaluate Omicron-specific vaccine
Latest NewsPfizer Inc and BioNTech SE have started clinical safety testing of an Omikron-specific vaccine in healthy adults 18 through 55 years of age.
Cytovation AS kicks-off with $20m Series A financing
Latest NewsNorway’s immuno-oncology specialist Cytovation A/S has raised $20m in a Series A financing led by early-stage investor Sandwater.
Immunovia with acting CEO
AppointmentsImmunovia AB announces that Philipp Mathieu has been appointed as acting CEO and President with immediate effect. The search for a permanent CEO continues, as previously communicated.
Valneva vaccine neutralises Omicron variant
Latest NewsFrench-Austrian vaccine specialist Valneva SE has demonstrated that its COVID-19 vaccine induced neutralisation of 87% of the Omicron variant.
Beckman Coulter receives IVDR certification covering more than 200 flow cytometry reagents
ProductsLeading the way with the industry’s largest portfolio of CE-IVD labeled flow cytometry reagents in the market, Beckman Coulter Life Sciences announces that it has received a EU Quality Management System Certificate under the new In Vitro Diagnostic Medical Devices Regulation (IVDR) for more than 200 flow cytometry reagents developed and manufactured at their Marseille, France facility.